Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q5106. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
32
Median % of Medicare
--
Rate range
$6.54 - $12.34
Q5106 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Alabama | $7.85 | -- | -- | 2026 |
| Arkansas | $11.36 | -- | -- | 2026 |
| Arizona | $7.10 | -- | -- | 2026 |
| California | $12.34 | -- | -- | 2026 |
| Connecticut | $7.82 | -- | -- | 2024 |
| District of Columbia | $7.57 | -- | Not required | 2026 |
| Iowa | $11.17 | -- | -- | 2024 |
| Idaho | $6.54 | -- | Required | 2026 |
| Illinois | $7.67 | -- | -- | 2026 |
| Indiana | $11.58 | -- | -- | 2018 |
| Kansas | $7.97 | -- | -- | 2026 |
| Kentucky | $7.57 | -- | -- | 2026 |
| Louisiana | $7.82 | -- | -- | 2026 |
| Maine | $7.97 | -- | -- | 2026 |
| Michigan | $7.97 | -- | -- | 2026 |
| Minnesota | $7.96 | -- | -- | 2026 |
| Mississippi | $7.88 | -- | -- | 2026 |
| Montana | $7.57 | -- | -- | 2026 |
| Nebraska | $7.96 | -- | -- | 2026 |
| New Hampshire | $11.30 | -- | Not required | 2026 |
| New Jersey | $10.92 | -- | Not required | 2026 |
| New Mexico | $7.47 | -- | -- | 2025 |
| Oklahoma | $7.97 | -- | -- | 2026 |
| Rhode Island | $8.00 | -- | -- | 2026 |
| South Carolina | $7.99 | -- | -- | 2026 |
| Texas | $7.57* | -- | -- | 2026 |
| Utah | $7.97* | -- | Required | 2026 |
| Virginia | $7.96 | -- | -- | 2026 |
| Vermont | $7.46 | -- | Required | 2026 |
| Washington | $7.97 | -- | -- | 2026 |
| Wisconsin | $7.97 | -- | -- | 2026 |
| Wyoming | $7.97 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 56 codes from Q5098 to Q5167 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q5106?
32 state Medicaid programs publish a fee-for-service rate for Q5106 (injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units), ranging from $6.54 in Idaho to $12.34 in California. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q5106?
California publishes the highest Medicaid rate for Q5106 at $12.34. Idaho publishes the lowest at $6.54.
Does Q5106 require prior authorization under Medicaid?
3 of the 32 publishing states flag Q5106 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".